year redwood citi calif. biopharmaceut
concern loss $ 1.40 share compar 1990
loss $ 4.6 million 31 cent share revenu fell
$ 4.3 million $ 8.9 million 1990. 1991 loss
includ $ 9.3 million noncash charg result
genelab acquisit new unit american biotech
resourc inc. loss $ 2.1 million
